Issue 7, 2024

Retraction: An MSN-PEG-IP drug delivery system and IL13Rα2 as targeted therapy for glioma

Abstract

Retraction of ‘An MSN-PEG-IP drug delivery system and IL13Rα2 as targeted therapy for glioma’ by Jinlong Shi et al., Nanoscale, 2017, 9, 8970–8981, https://doi.org/10.1039/C6NR08786H.

Associated articles

Article information

Article type
Retraction
Submitted
31 Jan 2024
Accepted
31 Jan 2024
First published
07 Feb 2024
This article is Open Access
Creative Commons BY license

Nanoscale, 2024,16, 3765-3765

Retraction: An MSN-PEG-IP drug delivery system and IL13Rα2 as targeted therapy for glioma

J. Shi, S. Hou, J. Huang, S. Wang, W. Huan, C. Huang, X. Liu, R. Jiang, W. Qian, J. Lu, X. Wang, W. Shi, R. Huang and J. Chen, Nanoscale, 2024, 16, 3765 DOI: 10.1039/D4NR90030H

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements